Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian Federation
NCT03549143 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2019-04-25
Summary
Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian Federation
Conditions
- Irritable Bowel Syndrome
Interventions
- OTHER
-
IBS
No intervention, description of routine practice only
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-25
- Primary Completion
- 2019-04-19
- Completion
- 2019-04-19
Countries
- Russia
Study Locations
More Related Trials
-
Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome
NCT02092402 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome
NCT05819281 ·Status: UNKNOWN ·Phase: PHASE2
-
Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome
NCT05379036 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients
NCT06433180 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome
NCT05874830 ·Status: RECRUITING ·Phase: NA
-
Traditional Dietary Advice Vs. Mediterranean Diet in IBS
NCT05985018 ·Status: COMPLETED ·Phase: NA
-
Manipulation of Visceral Sensitivity and Immune System in IBS
NCT00418340 ·Status: UNKNOWN ·Phase: PHASE4
-
IBS-C Questionnaire Study
NCT04968652 ·Status: COMPLETED
-
The Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults
NCT05340400 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)
NCT01340053 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS
NCT02847481 ·Status: COMPLETED ·Phase: PHASE1
-
Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predominant Constipation and Methane Production
NCT06801184 ·Status: RECRUITING
-
Factors Affecting Dissatisfaction to Treatments in Patients With Chronic Constipation and IBS With Constipation
NCT02813616 ·Status: COMPLETED
-
Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China
NCT02955316 ·Status: COMPLETED
-
Anorectal Manometry of Patients With Constipation Predominant IBS
NCT05921383 ·Status: NOT_YET_RECRUITING
-
Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel Syndrome
NCT01803724 ·Status: UNKNOWN
-
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating
NCT02299973 ·Status: COMPLETED ·Phase: NA
-
Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome
NCT00738920 ·Status: COMPLETED ·Phase: NA
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Faecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT04899869 ·Status: COMPLETED ·Phase: NA
-
Ethosuximide to Treat IBS
NCT02973542 ·Status: COMPLETED ·Phase: PHASE2
-
A Pharmacy-based Observational Study to Learn More About Iberogast Advance in the Real-world Setting
NCT05389709 ·Status: COMPLETED
-
Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome.
NCT01297556 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Internet Delivered Cognitive Behavior Therapy (CBT) for Irritable Bowel Syndrome (IBS)
NCT00844961 ·Status: COMPLETED ·Phase: NA
-
Assessment of Psychological Symptoms and Health Related Quality of Life in Patients With Irritable Bowel Syndrome
NCT05480059 ·Status: UNKNOWN